HSDT vs. NSPR, BDMD, OBIO, FONR, EDAP, ZJYL, NTRB, APYX, VANI, and ICCM
Should you be buying Helius Medical Technologies stock or one of its competitors? The main competitors of Helius Medical Technologies include InspireMD (NSPR), Baird Medical Investment (BDMD), Orchestra BioMed (OBIO), Fonar (FONR), Edap Tms (EDAP), Jin Medical International (ZJYL), Nutriband (NTRB), Apyx Medical (APYX), Vivani Medical (VANI), and IceCure Medical (ICCM). These companies are all part of the "medical equipment" industry.
Helius Medical Technologies vs. Its Competitors
InspireMD (NYSE:NSPR) and Helius Medical Technologies (NASDAQ:HSDT) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, media sentiment, valuation, risk and institutional ownership.
44.8% of InspireMD shares are held by institutional investors. Comparatively, 18.6% of Helius Medical Technologies shares are held by institutional investors. 34.1% of InspireMD shares are held by insiders. Comparatively, 17.9% of Helius Medical Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
InspireMD has a net margin of -413.96% compared to Helius Medical Technologies' net margin of -7,215.25%. InspireMD's return on equity of -69.42% beat Helius Medical Technologies' return on equity.
In the previous week, Helius Medical Technologies had 6 more articles in the media than InspireMD. MarketBeat recorded 6 mentions for Helius Medical Technologies and 0 mentions for InspireMD. Helius Medical Technologies' average media sentiment score of 0.77 beat InspireMD's score of 0.00 indicating that Helius Medical Technologies is being referred to more favorably in the news media.
Helius Medical Technologies has lower revenue, but higher earnings than InspireMD. InspireMD is trading at a lower price-to-earnings ratio than Helius Medical Technologies, indicating that it is currently the more affordable of the two stocks.
InspireMD has a beta of 0.6, indicating that its stock price is 40% less volatile than the S&P 500. Comparatively, Helius Medical Technologies has a beta of 1, indicating that its stock price has a similar volatility profile to the S&P 500.
InspireMD presently has a consensus target price of $4.50, suggesting a potential upside of 88.28%. Given InspireMD's stronger consensus rating and higher possible upside, equities research analysts clearly believe InspireMD is more favorable than Helius Medical Technologies.
Summary
InspireMD beats Helius Medical Technologies on 10 of the 16 factors compared between the two stocks.
Get Helius Medical Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for HSDT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding HSDT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Helius Medical Technologies Competitors List
Related Companies and Tools
This page (NASDAQ:HSDT) was last updated on 10/5/2025 by MarketBeat.com Staff
Free HSDT Stock Alerts